World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
46037
World Ranking
7563
National Ranking
3943

Overview

Joseph P. McEvoy is affiliated with Augusta University in the United States. Their research primarily focuses on Medicine with a specialization in Psychiatry and Mental Health, contributing significantly to related subfields such as Experimental and Cognitive Psychology, Physiology, Clinical Psychology, and Biological Psychiatry.

The main topics addressed in their work include:

  • Schizophrenia research and treatment
  • Sleep and related disorders
  • Bipolar Disorder and Treatment
  • Tryptophan and brain disorders
  • Diet and metabolism studies
  • Treatment of Major Depression
  • Attention Deficit Hyperactivity Disorder

Joseph P. McEvoy has published extensively, with notable recent papers including:

  • Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia (2021, CNS Drugs)
  • Longitudinal study of inflammatory markers and psychopathology in schizophrenia (2020, Schizophrenia Research)
  • Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness (2021, The Journal of Clinical Psychiatry)
  • Meta-analysis of clozapine and insomnia in schizophrenia (2023, Schizophrenia Research)
  • Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial (2022, BMC Psychiatry)

The venues where Joseph P. McEvoy frequently publishes include:

  • UNC Libraries
  • The Journal of Clinical Psychiatry
  • Schizophrenia Research
  • BMC Psychiatry
  • Medicine & Science in Sports & Exercise

The list of frequent co-authors includes:

  • T. Scott Stroup
  • Jeffrey A. Lieberman
  • Marvin S. Swartz
  • Robert A. Rosenheck
  • Sonia M. Davis

Best Publications

  • Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    Jeffrey A. Lieberman;T. Scott Stroup;Joseph Patrick McEvoy;Joseph Patrick McEvoy;Marvin S. Swartz

  • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

    Joseph Patrick McEvoy;Jonathan M. Meyer;Donald C. Goff;Henry A. Nasrallah

  • Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

    Richard S.E. Keefe;Robert M. Bilder;Sonia M. Davis;Philip D. Harvey

  • Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    Joseph Patrick McEvoy;Jeffrey A. Lieberman;T. Scott Stroup;Sonia M. Davis

  • A National Study of Violent Behavior in Persons With Schizophrenia

    Jeffrey W. Swanson;Marvin S. Swartz;Richard A. Van Dorn;Eric B. Elbogen

  • Antipsychotic drug effects on brain morphology in first-episode psychosis

    Jeffrey A. Lieberman;Jeffrey A. Lieberman;Gary D. Tollefson;Cecil Charles;Robert Zipursky

  • Insight in schizophrenia. Its relationship to acute psychopathology.

    Joseph P. McEvoy;L. Joy Apperson;Paul S. Appelbaum;Priscilla Ortlip

  • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

    Robert M. Bilder;Robert S. Goldman;Jan Volavka;Pal Czobor

  • Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.

    Henry A. Nasrallah;Jonathan M. Meyer;Donald C. Goff;Joseph Patrick McEvoy

  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

    Alan S. Bellack;Charles L. Bowden;Christopher R. Bowie;Matthew J. Byerly

  • The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

    T. Scott Stroup;Joseph Patrick McEvoy;Marvin S. Swartz;Matthew J. Byerly

  • Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

    Jean Pierre Lindenmayer;Pal Czobor;Jan Volavka;Leslie Citrome

  • A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

    Donald C. Goff;Lisa M. Sullivan;Joseph Patrick McEvoy;Jonathan M. Meyer

  • Barriers to Employment for People With Schizophrenia

    Robert Rosenheck;Douglas Leslie;Richard Keefe;Joseph McEvoy

  • Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

    Richard S.E. Keefe;Robert M. Bilder;Philip D. Harvey;Sonia M. Davis

  • Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

    Jan Volavka;Pal Czobor;Brian Sheitman;Jean Pierre Lindenmayer

  • Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic

    T. Scott Stroup;Jeffrey A. Lieberman;Joseph P. McEvoy;Marvin S. Swartz

  • A genome-wide investigation of SNPs and CNVs in schizophrenia

    Anna C. Need;Dongliang Ge;Michael E. Weale;Jessica Maia

  • Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

    Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.

    Joseph Patrick McEvoy;Gerard E. Hogarty;Sandra Steingard

Frequent Co-Authors

Jeffrey A. Lieberman
Jeffrey A. Lieberman Columbia University
Marvin S. Swartz
Marvin S. Swartz Duke University
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Robert A. Rosenheck
Robert A. Rosenheck Yale University
Diana O. Perkins
Diana O. Perkins University of North Carolina at Chapel Hill
Leslie Citrome
Leslie Citrome New York Medical College
T. Scott Stroup
T. Scott Stroup Columbia University
Jan Volavka
Jan Volavka New York University
William H. Wilson
William H. Wilson Duke University
Mauricio Tohen
Mauricio Tohen University of New Mexico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA goes beyond the traditional MD route. Today, there are flexible online options catering to different goals and schedules. Many students consider online nursing degrees due to their affordability and accessibility. If you’re looking to advance from RN to BSN without breaking the bank, you should check out the cheapest rn to bsn online programs, which are budget-friendly and offer accredited coursework.

For those without prior nursing experience, entry level msn programs online allow a direct path to a master’s in nursing, opening doors to advanced practice roles. If you’re just starting out and are concerned about admissions competitiveness, consider nursing schools with high acceptance rates as a great first step into the field.

Not everyone interested in healthcare wants to provide direct patient care. Programs in medical administration can be completed fully online as well. Explore careers in healthcare management by browsing some of the medical billing and coding schools online with flexible schedules and the opportunity for financial aid.

Best Scientists Citing Joseph P. McEvoy

Trending Scientists

Recently Published Articles